188 related articles for article (PubMed ID: 31254367)
1. High daily salt intake had a negative impact on how well nocturnal enuresis treatment worked on children aged 7-10 years.
Tsuji S; Yamaguchi T; Akagawa Y; Akagawa S; Kino J; Yamanouchi S; Kimata T; Kaneko K
Acta Paediatr; 2020 Jan; 109(1):193-197. PubMed ID: 31254367
[TBL] [Abstract][Full Text] [Related]
2. Desmopressin response in nocturnal enuresis showing concentrated urine.
Akagawa S; Tsuji S; Akagawa Y; Yamanouchi S; Kimata T; Kaneko K
Pediatr Int; 2020 Jun; 62(6):701-704. PubMed ID: 32065484
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
[TBL] [Abstract][Full Text] [Related]
4. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
Kamperis K; Rittig S; Radvanska E; Jørgensen KA; Djurhuus JC
J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
[TBL] [Abstract][Full Text] [Related]
6. Desmopressin response in nocturnal enuresis without nocturnal polyuria in Japanese children.
Akagawa S; Tsuji S; Akagawa Y; Yamanouchi S; Kimata T; Kaneko K
Int J Urol; 2021 Sep; 28(9):964-968. PubMed ID: 34169597
[TBL] [Abstract][Full Text] [Related]
7. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
Ikeda H; Watanabe T; Isoyama K
Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal polyuria in monosymptomatic nocturnal enuresis refractory to desmopressin treatment.
Kamperis K; Rittig S; Jørgensen KA; Djurhuus JC
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1232-40. PubMed ID: 16804103
[TBL] [Abstract][Full Text] [Related]
9. Effect of indomethacin on desmopressin resistant nocturnal polyuria and nocturnal enuresis.
Kamperis K; Rittig S; Bower WF; Djurhuus JC
J Urol; 2012 Nov; 188(5):1915-22. PubMed ID: 22999686
[TBL] [Abstract][Full Text] [Related]
10. The use of desmopressin in the management of nocturnal enuresis in patients with spinal cord injury.
Zahariou A; Karagiannis G; Papaioannou P; Stathi K; Michail X
Eura Medicophys; 2007 Sep; 43(3):333-8. PubMed ID: 17021585
[TBL] [Abstract][Full Text] [Related]
11. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
Önol FF; Guzel R; Tahra A; Kaya C; Boylu U
J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics, nocturnal antidiuretic hormone levels, and responsiveness to DDAVP of school children with primary nocturnal enuresis.
Chang JW; Yang LY; Chin TW; Tsai HL
World J Urol; 2012 Aug; 30(4):567-71. PubMed ID: 21898084
[TBL] [Abstract][Full Text] [Related]
13. Editorial Comment to Desmopressin response in nocturnal enuresis without nocturnal polyuria in Japanese children.
Kanematsu A
Int J Urol; 2021 Sep; 28(9):969. PubMed ID: 34245046
[No Abstract] [Full Text] [Related]
14. Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.
Montaldo P; Tafuro L; Rea M; Narciso V; Iossa AC; Del Gado R
BJU Int; 2012 Oct; 110(8 Pt B):E381-6. PubMed ID: 22313792
[TBL] [Abstract][Full Text] [Related]
15. Management of treatment-resistant nocturnal enuresis.
Tsuji S; Kaneko K
Pediatr Int; 2023; 65(1):e15573. PubMed ID: 37428825
[TBL] [Abstract][Full Text] [Related]
16. Constipation in nocturnal enuresis may interfere desmopressin management success.
Ma Y; Shen Y; Liu X
J Pediatr Urol; 2019 Apr; 15(2):177.e1-177.e6. PubMed ID: 30594475
[TBL] [Abstract][Full Text] [Related]
17. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
Van de Walle J; Van Herzeele C; Raes A
Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
[TBL] [Abstract][Full Text] [Related]
18. Desmopressin versus desmopressin + oxybutynin in the treatment of children with nocturnal enuresis.
Gözüküçük A; Kılıç M; Çakıroğlu B
J Pediatr Urol; 2021 Aug; 17(4):451.e1-451.e6. PubMed ID: 33931318
[TBL] [Abstract][Full Text] [Related]
19. Reduced anti-diuretic response to desmopressin during wet nights in patients with monosymptomatic nocturnal enuresis.
Tauris LH; Andersen RF; Kamperis K; Hagstroem S; Rittig S
J Pediatr Urol; 2012 Jun; 8(3):285-90. PubMed ID: 21514237
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis.
Hunsballe JM; Hansen TK; Rittig S; Pedersen EB; Djurhuus JC
Clin Endocrinol (Oxf); 1998 Dec; 49(6):793-801. PubMed ID: 10209568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
